Premium
APLAR rheumatoid arthritis treatment recommendations
Author(s) -
Lau Chak Sing,
Chia Faith,
Harrison Andrew,
Hsieh TsuYi,
Jain Rahul,
Jung Seung Min,
Kishimoto Mitsumasa,
Kumar Ashok,
Leong Khai Pang,
Li Zhanguo,
Lichauco Juan Javier,
Louthrenoo Worawit,
Luo ShueFen,
Nash Peter,
Ng Chin Teck,
Park SungHwan,
Suryana Bagus Putu Putra,
Suwannalai Parawee,
Wijaya Linda Kurniaty,
Yamamoto Kazuhiko,
Yang Yue,
Yeap Swan Sim
Publication year - 2015
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.12754
Subject(s) - rheumatoid arthritis , medicine , rheumatology , asia pacific , league , population , alternative medicine , physical therapy , family medicine , intensive care medicine , environmental health , pathology , physics , astronomy , international trade , business
Aims Rheumatoid arthritis is a chronic inflammatory condition that affects approximately 1% of the world's population. There are a wide number of guidelines and recommendations available to support the treatment of rheumatoid arthritis; however, the evidence used for these guidelines is predominantly based on studies in Caucasian subjects and may not be relevant for rheumatoid arthritis patients in the Asia‐Pacific region. Therefore, the Asia Pacific League of Associations for Rheumatology established a Steering Committee in 2013 to address this issue. Materials and methods The AGREE II instrument and the ADAPTE Collaboration framework were applied to systematically identify, appraise, synthesize, and adapt international rheumatoid arthritis guidelines for use in the Asia‐Pacific region. Results Forty rheumatoid arthritis treatment recommendations, based on evidence and expert opinion, were drafted and are presented in this report. Conclusion The Asia Pacific of Associations for Rheumatology rheumatoid arthritis treatment recommendations are intended to serve as a reference for best practice management of rheumatoid arthritis in Asia‐Pacific, focusing on local issues to ensure the delivery of basic care for these patients, and to improve their outcomes. In addition, the document will serve as a reference for national rheumatology associations in Asia‐Pacific for developing guidelines in their respective countries.